PRE 14A

Proxy Statement (Preliminary)

Protalix BioTherapeutics, Inc. Filed 2018-10-05 Acc 0001144204-18-052765

Documents 1

PRE 14A Proxy Statement (Preliminary) , tv504256-pre14a.htm

Around this filing

2019-10-04 PRE 14A Proxy Statement (Preliminary)
2018-10-05 PRE 14A Proxy Statement (Preliminary)
2018-10-05 8-K Regulation FD disclosure
2018-02-23 PRE 14A Proxy Statement (Preliminary)

Link to a passage

External

SEC EDGAR (opens in new tab)